Product NDC: | 58809-571 |
Proprietary Name: | VANACOF |
Non Proprietary Name: | Chlophedianol Hydrochloride, Guaifenesin |
Active Ingredient(s): | 25; 200 mg/5mL; mg/5mL & nbsp; Chlophedianol Hydrochloride, Guaifenesin |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58809-571 |
Labeler Name: | GM Pharmaceuticals, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20110606 |
Package NDC: | 58809-571-01 |
Package Description: | 473 mL in 1 BOTTLE (58809-571-01) |
NDC Code | 58809-571-01 |
Proprietary Name | VANACOF |
Package Description | 473 mL in 1 BOTTLE (58809-571-01) |
Product NDC | 58809-571 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlophedianol Hydrochloride, Guaifenesin |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20110606 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | GM Pharmaceuticals, Inc. |
Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN |
Strength Number | 25; 200 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes |